Aurinia Pharmaceuticals AUPH
NASDAQ AUPH
$16.42 -0.10 (-0.61%)
At close: Sep 29, 2026 · 4:00 PM EDT

Aurinia Pharmaceuticals (AUPH) Restructuring Costs (2024 - 2025)

Updated

Aurinia Pharmaceuticals' Restructuring Costs was $1.65 million in FY2025, down 92.9% from $23.11 million in FY2024.

Analysis

Aurinia Pharmaceuticals (AUPH) Restructuring Costs (2024 - 2025) Analysis & Trends

  • Per Business Quant data, Restructuring Costs in earlier years was $23.11 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Aurinia Pharmaceuticals 2.20 Bn 623.91 Mn 76.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 114,000.00
Mar 31, 2025 1.53 Mn
Dec 31, 2024 15.35 Mn
Jun 30, 2024 1.07 Mn
Mar 31, 2024 6.68 Mn
API Access

Aurinia Pharmaceuticals Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=AUPH&period=max&api_key=YOUR_API_KEY